Antares Pharma (ATRS) News Today

Notice: This company has been marked as potentially delisted and may not be actively trading.

Today's Range: $5.59
▼
$5.59
50-Day Range: $5.59
▼
$5.59
52-Week Range: $3.11
▼
$5.60

Volume: 6 shs
Average Volume: 3.29 million shs
Market Capitalization: $955.06 million

P/E Ratio: 23.29
Dividend Yield: N/A
Price Target: N/A

Source

Source	Headline
	Antares Vision Share Price (AV.MI) lse.co.uk - December 7 at 7:11 PM
	Aprea Therapeutics’ Promising Clinical Data and Distinctive Drug Profile: An Analysis of Jason McCarthy’s Buy Rating markets.businessinsider.com - October 19 at 10:34 AM
	Antares Reaches New 52-Week High (AIS) thestreet.com - September 3 at 2:09 AM
	Antares Vision SpA (ANV) investing.com - August 2 at 6:59 AM
	COP Syringes Market Competitive Situation By 2030 marketwatch.com - April 27 at 12:48 PM
	Pharma Track and Trace Solutions Market Trends By 2031 marketwatch.com - April 6 at 8:56 AM
	Transdermal Patch Drug Delivery System Market Size, Share, Demand, Opportunity, Outlook, Trends, Revenue, and Future Growth 2027 marketwatch.com - March 28 at 3:07 PM
	Drug Transport Technology Market Top Players By 2031 marketwatch.com - March 27 at 12:48 AM
	Drug Delivery Technology Market 2023 Size and Forecast to 2030 marketwatch.com - March 25 at 12:28 AM
	Pharma Track and Trace Solutions Market Forecast 2023 To 2029 Size, Global Predictive Analytics marketwatch.com - March 4 at 2:21 AM
	Global Genitourinary Drugs Market Report 2022 to 2027: Featuring Allergan, Antares Pharma, Bayer and Novartis Among Others yahoo.com - February 17 at 3:45 PM
	Pharma Track and Trace Solutions Market : Analysis, Forecast, Size, New Trends and Insights, Update, COVID-19 Impact marketwatch.com - January 4 at 9:39 AM
	Pharma Track and Trace Solutions Market 2022 : Incredible Possibilities, Growth Analysis and Forecast To 2028 marketwatch.com - December 16 at 9:18 AM
	Drug Delivery Technology Market Global Demand, Opportunities, Trends, Analysis and Forecast to 2030 marketwatch.com - December 1 at 5:31 PM
	Pharmaceutical Drug Delivery Global Market Report 2022 yahoo.com - September 14 at 3:29 AM
	Pharma Track and Trace Solutions Market Report Detailed Market Analysis and Forecasts 2022 To 2028 \| 112 Pages Report marketwatch.com - August 20 at 4:37 AM
	Looking Into Antares Pharma's Return On Invested Capital msn.com - June 8 at 3:14 PM
	marketbeat.com - May 24 at 6:02 AM
	Halozyme: Antares Pharma Bolsters Growth Prospects seekingalpha.com - May 19 at 5:43 AM
	MiMedx Group and Inozyme Stock See Action From Activist Investors finance.yahoo.com - May 6 at 6:11 PM
	HALOZYME COMMENCES TENDER OFFER FOR ALL OUTSTANDING SHARES OF COMMON STOCK OF ANTARES PHARMA finance.yahoo.com - April 26 at 10:31 AM
	Looking Into Antares Pharma Inc's Recent Short Interest benzinga.com - April 14 at 9:50 AM
	Antares Pharma (ATRS) Moves 49.2% Higher: Will This Strength Last? finance.yahoo.com - April 14 at 9:50 AM
	Antares Pharma to be acquired by Halozyme in $960M deal finance.yahoo.com - April 13 at 3:30 PM
	Why Is Antares Pharma (ATRS) Stock Up Today? investorplace.com - April 13 at 11:06 AM
	Antares Pharma stock rockets after Halozyme buyout deal for a near-50% premium morningstar.com - April 13 at 10:30 AM
	Why Antares Pharma Stock Is Bolting Higher Today fool.com - April 13 at 8:33 AM
	Antares Pharma Announces FDA Approval Of TLANDO(TM), an Oral Treatment for Testosterone Replacement Therapy stockhouse.com - March 29 at 9:29 AM
	The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia msn.com - March 29 at 9:29 AM
	Antares wins full FDA approval for testosterone replacement therapy seekingalpha.com - March 29 at 9:29 AM
	Antares Pharma Announces FDA Approval Of TLANDO™, an Oral Treatment for Testosterone Replacement Therapy finance.yahoo.com - March 29 at 9:29 AM
	Antares Pharma's Return On Capital Employed Overview benzinga.com - March 8 at 3:02 PM
	Antares Pharma (ATRS) Investor Presentation - Slideshow seekingalpha.com - March 8 at 1:39 PM
	Zacks Investment Research Upgrades Antares Pharma (NASDAQ:ATRS) to Hold marketbeat.com - March 7 at 5:32 PM
	Antares Pharma: Q4 Earnings Snapshot apnews.com - March 3 at 10:10 AM
	Antares Pharma Reports Fourth Quarter and Full-Year 2021 Financial and Operating Results finance.yahoo.com - March 3 at 10:10 AM
	Antares Pharma (ATRS) Surpasses Q4 Earnings and Revenue Estimates finance.yahoo.com - March 3 at 10:10 AM
	SmileDirectClub (SDC) Reports Q4 Loss, Lags Revenue Estimates finance.yahoo.com - February 28 at 8:27 PM
	Antares Pharma to Present at the Cowen 42nd Annual Healthcare Conference finance.yahoo.com - February 28 at 12:15 PM
	Antares Pharma (NASDAQ:ATRS) Could Easily Take On More Debt finance.yahoo.com - February 18 at 7:35 AM
	Henry Schein (HSIC) Q4 Earnings and Revenues Beat Estimates finance.yahoo.com - February 15 at 10:57 AM
	Here's Why I Think Antares Pharma (NASDAQ:ATRS) Might Deserve Your Attention Today nasdaq.com - January 13 at 8:32 AM
	Antares Pharma, Inc.'s (NASDAQ:ATRS) Stock's On An Uptrend: Are Strong Financials Guiding The Market? finance.yahoo.com - January 13 at 8:32 AM
	Antares Pharma Appoints Claude E. Richardson as Senior Vice President of Human Resources finance.yahoo.com - January 12 at 12:21 PM
	Antares Pharma Announces Positive Results From Phase I Study For ATRS-1902 For Adrenal Crisis Rescue finance.yahoo.com - January 11 at 9:06 AM
	MedMira strengthen its Board with New Appointment finance.yahoo.com - December 17 at 8:58 AM
	Assertio Shares Gain After Buying Antares' Rheumatoid Arthritis Treatment For $44M markets.businessinsider.com - December 16 at 9:29 AM
	If You Like EPS Growth Then Check Out Antares Pharma (NASDAQ:ATRS) Before It's Too Late finance.yahoo.com - December 8 at 8:29 AM
	LPCN: Antares Agreement & NASH Fast Track Change the Calculus finance.yahoo.com - November 8 at 3:50 PM
	Antares Pharma: Q3 Earnings Snapshot sfgate.com - November 4 at 8:20 AM

Get Antares Pharma News Delivered to You Automatically

ATRS Media Mentions By Week

ATRS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ATRS
News Sentiment
▼
0.00

0.51
▲
Average
Medical
News Sentiment

ATRS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ATRS Articles
This Week
▼
1

0
▲
ATRS Articles
Average Week

Get Antares Pharma News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:ATRS) was last updated on 12/9/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Antares Pharma (ATRS) News Today

ATRS Media Mentions By Week

ATRS Media Sentiment

ATRS News Coverage

Related Companies and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info